Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 755.75

+2.5%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Biotech Jim

scaram(o)uche

To: Miljenko Zuanic who wrote (2111)	5/11/2017 12:28:05 AM
From: Miljenko Zuanic	2 Recommendations of 3559

I am bit surprise that there is no single comment on this news (also on tweeter). My point is that Dupi may become "cure" (corrector, vaccine...better say) for atopic (allergic) diseases in pediatric population (where all started), due to dual receptors interaction (correcting Th2 response). Much differentiated from IL-5, IL-13, IL-4, Il-17, IL-22,.., antagonists. Projecting significant change in market value.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next